Home › Funds › Novo Holdings A/S › MIRM
Novo Holdings A/S position in MIRM
MIRUM PHARMACEUTICALS INC · Health Care
Novo Holdings A/S reported holding 1,125,000 shares of MIRM (MIRUM PHARMACEUTICALS INC) in its Q3 2026 13F filing — a position valued at US$96.2M, representing 6.46% of its reported portfolio and ranking #6 among its reported holdings. Novo Holdings A/S has disclosed MIRM holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR
How Novo Holdings A/S's MIRM position evolved
Novo Holdings A/S first disclosed a stake in MIRM in Q3 2023 at 1,500,000 shares (US$47.4M). The position peaked in Q2 2026 at 1,125,000 shares, worth US$131.7M. Across 13 filings, Novo Holdings A/S increased the stake 1 time(s), trimmed it 2 time(s) and left it unchanged 9 time(s). The most recent filing (Q3 2026) shows 1,125,000 shares valued at US$96.2M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 1.50M | $47.40M | New |
| Q4 2023 | 1.50M | $44.28M | Hold |
| Q1 2024 | 1.50M | $37.68M | Hold |
| Q2 2024 | 1.50M | $51.28M | Hold |
| Q3 2024 | 1.50M | $58.50M | Hold |
| Q4 2024 | 1.50M | $62.02M | Hold |
| Q1 2025 | 1.50M | $67.58M | Hold |
| Q2 2025 | 1.50M | $76.34M | Hold |
| Q3 2025 | 1.26M | $92.67M | Reduce |
| Q4 2025 | 1.26M | $99.85M | Hold |
| Q1 2026 | 1.32M | $122.40M | Add |
| Q2 2026 | 1.12M | $131.70M | Reduce |
| Q3 2026 | 1.12M | $96.17M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About MIRM and 13F data
MIRM (MIRUM PHARMACEUTICALS INC) is a Health Care company. 38 other funds we track also report a position in MIRM — the largest reported positions include Frazier Life Sciences Management, L.P. (US$656.5M), EVENTIDE ASSET MANAGEMENT, LLC (US$106.7M), TANG CAPITAL MANAGEMENT LLC (US$105.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding MIRM
- Frazier Life Sciences Management, L.P. 7.68M sh · $656.46M · Q3 2026
- EVENTIDE ASSET MANAGEMENT, LLC 1.25M sh · $106.72M · Q3 2026
- TANG CAPITAL MANAGEMENT LLC 1.24M sh · $105.66M · Q3 2026
- TCG Crossover Management, LLC 1.12M sh · $95.65M · Q3 2026
- Rock Springs Capital Management LP 779.79K sh · $66.66M · Q3 2026
- TENOR CAPITAL MANAGEMENT Co., L.P. 17.15M sh · $47.20M · Q3 2026
- EMERALD ADVISERS, LLC 469.77K sh · $40.16M · Q3 2026
More on Novo Holdings A/S
FAQ
How long has Novo Holdings A/S held MIRM?
Novo Holdings A/S has disclosed MIRM holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is Novo Holdings A/S's current position in MIRM?
As of Q3 2026, Novo Holdings A/S holds 1.12M shares of MIRM (MIRUM PHARMACEUTICALS INC), valued at $96.17M, representing 6.46% of its reported portfolio and ranking #6.
Has Novo Holdings A/S been buying or selling MIRM?
In the latest 13F filing (Q3 2026), Novo Holdings A/S held unchanged its position in MIRM. The position peaked in Q2 2026 at 1.12M shares.
Which other funds hold MIRM?
Other major institutional holders of MIRM include Frazier Life Sciences Management, L.P., EVENTIDE ASSET MANAGEMENT, LLC, TANG CAPITAL MANAGEMENT LLC, among 38 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.